论文信息 - Adavosertib with chemotherapy (CT) in patients (pts) with platinum-resistant ovarian cancer (PPROC): An open label, four-arm, phase II study. - 字舞流文

Adavosertib with chemotherapy (CT) in patients (pts) with platinum-resistant ovarian cancer (PPROC): An open label, four-arm, phase II study.

Suzanne F. Jones | A. Oza | J. Cragun | K. Cadoo | G. Konecny | Z. Lai | D. Spigel | J. Chmielecki | J. Geenen | S. Chambers | Sanjeev Kumar | E. Hamilton | G. Mugundu | S. Ghamande | S. Plaxe | D. Spitz | Lee-may Chen | T. Troso-Sandoval | K. Moore | Esteban Rodrigo Imedio